As the repertoire of biologics in IBD expands, so does the volume of data generated from clinical trials. It is increasingly difficult for clinicians to keep up to date with the wealth of reports presented from clinical trials and real life experiences.
This course is designed to guide clinicians on the optimal approach to prescribing biologics based on evidence generated from the diverse clinical studies.
The format will be lectures and clinical cases with an external faculty. It is appropriate for teams of IBD nurses and gastroenterologists or for individuals managing IBD patients wanting to consolidate their clinical practice.
Target Audience: IBD teams including gastroenterologists and nurses or for individuals managing IBD patients wanting to consolidate their clinical practice.
Learning Style: The format will be lectures and clinical cases with an external faculty.
Learning Objectives:
- Study day designed to guide clinicians on the optimal approach to prescribing biologics based on evidence generated from the diverse clinical studies.
- Translate clinical evidence into good practice
Accreditation:
5 CPD points awarded by The Association of Coloproctology of Great Britain & Ireland
[file url="http://www.stmarksacademicinstitute.org.uk/content/uploads/2018/03/Prescribing-Biologics-in-IBD-2018-programme.pdf" title ="Prescribing Biologics in IBD 2018 programme"]
For queries or further information, please email:
info@stmarksacademicinstitute.org.uk.
Register here